Home › Parkinson's Disease › New Mexico
Parkinson's Disease clinical trials in New Mexico
5 studies for Parkinson's Disease are looking for participants at sites in New Mexico.
Cities in New Mexico
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #014, Albuquerque
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of New Mexico Health Sciences Center (Site #225), Albuquerque
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of New Mexico, Albuquerque
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of New Mexico, Albuquerque
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of New Mexico, Albuquerque
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Aug 28, 2026 · NCT06680830From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.